Associations of nm23H1, VEGF-C, and VEGF-3 Receptor in Human Prostate Cancer
AbstractWe studied the expression of the non-metastatic clone 23 type 1 (nm23H1) gene, vascular endothelial growth factor (VEGF)-C, and its receptor VEGFR-3 using an in situ hybridization technique and immunohistochemical analyses with prostate cancer tissues and adjacent benign tissues of 52 human archival cases. The association between VEGF-C expression, microlymphatic count (MLC), and staining intensity for nm23H1 and VEGFR-3 was used to evaluate tumor metastasis and survival rate. MLC values were significantly higher in tumorous tissue than in non-cancerous tissue. VEGF-C mRNA, VEGFR-3, and nm23H1 were highly expressed in tumorous tissue. VEGFR-3 expression was greater in VEGF-C mRNA-positive tumors than in VEGF-C mRNA-negative tumors. The association of VEGFR-3 expression with VEGF-C mRNA and MLC suggested that the poor prognosis and tumor metastasis associated with VEGFR-3 expression may be due, in part, to its role in promoting angiogenesis. VEGF-C expression was significantly associated with tumor lymphangiogenesis, angiogenesis, and immune response as a potent multifunctional stimulating factor in prostate cancer. Expression of nm23H1 was significantly inversely correlated with lymph node metastasis. Furthermore, there was a strong negative correlation between the expression of nm23H1, VEGF-C mRNA, and MLC. These findings provide important information for prophylactic, diagnostic, and therapeutic strategies for prostate cancer. View Full-Text
Share & Cite This Article
Yang, Z.-S.; Xu, Y.-F.; Huang, F.-F.; Ding, G.-F. Associations of nm23H1, VEGF-C, and VEGF-3 Receptor in Human Prostate Cancer. Molecules 2014, 19, 6851-6862.
Yang Z-S, Xu Y-F, Huang F-F, Ding G-F. Associations of nm23H1, VEGF-C, and VEGF-3 Receptor in Human Prostate Cancer. Molecules. 2014; 19(5):6851-6862.Chicago/Turabian Style
Yang, Zui-Su; Xu, Yin-Feng; Huang, Fang-Fang; Ding, Guo-Fang. 2014. "Associations of nm23H1, VEGF-C, and VEGF-3 Receptor in Human Prostate Cancer." Molecules 19, no. 5: 6851-6862.